These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34851805)

  • 1. DC-CTL targeting carbonic anhydrase IX gene combined with iAPA therapy in the treatment of renal cell carcinoma.
    Ma H; Tan Y; Wen D; Qu N; Kong Q; Li K; Ma S; Zhang J
    Hum Vaccin Immunother; 2021 Nov; 17(11):4363-4373. PubMed ID: 34851805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of anti-tumour immune response using dendritic cells pulsed with carbonic anhydrase IX-Acinetobacter baumannii outer membrane protein A fusion proteins against renal cell carcinoma.
    Kim BR; Yang EK; Kim DY; Kim SH; Moon DC; Lee JH; Kim HJ; Lee JC
    Clin Exp Immunol; 2012 Jan; 167(1):73-83. PubMed ID: 22132887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostimulatory activity of dendritic cells pulsed with carbonic anhydrase IX and Acinetobacter baumannii outer membrane protein A for renal cell carcinoma.
    Kim BR; Yang EK; Kim SH; Moon DC; Kim HJ; Lee JC; Kim DY
    J Microbiol; 2011 Feb; 49(1):115-20. PubMed ID: 21369988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene.
    Hernández JM; Bui MH; Han KR; Mukouyama H; Freitas DG; Nguyen D; Caliliw R; Shintaku PI; Paik SH; Tso CL; Figlin RA; Belldegrun AS
    Clin Cancer Res; 2003 May; 9(5):1906-16. PubMed ID: 12738749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells.
    Bleumer I; Tiemessen DM; Oosterwijk-Wakka JC; Völler MC; De Weijer K; Mulders PF; Oosterwijk E
    J Immunother; 2007 Jan; 30(1):116-22. PubMed ID: 17198090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of kidney cancer-specific antitumor immune responses using peripheral blood monocytes transduced with a recombinant adenovirus encoding carbonic anhydrase 9.
    Mukouyama H; Janzen NK; Hernandez JM; Lam JS; Caliliw R; Wang AY; Figlin RA; Belldegrun AS; Zeng G
    Clin Cancer Res; 2004 Feb; 10(4):1421-9. PubMed ID: 14977845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation.
    Duivenvoorden WC; Hopmans SN; Gallino D; Farrell T; Gerdes C; Glennie D; Lukka H; Pinthus JH
    Oncol Rep; 2015 Oct; 34(4):1968-76. PubMed ID: 26252502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of antigen specific cellular immunity by vaccination with peptides from MN/CA IX in renal cell carcinoma.
    Shimizu K; Uemura H; Yoshikawa M; Yoshida K; Hirao Y; Iwashima K; Saga S; Yoshikawa K
    Oncol Rep; 2003; 10(5):1307-11. PubMed ID: 12883698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
    Jakubicková L; Biesová Z; Pastoreková S; Kettmann R; Pastorek J
    Int J Oncol; 2005 Apr; 26(4):1121-7. PubMed ID: 15754010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse models.
    Birkhäuser FD; Koya RC; Neufeld C; Rampersaud EN; Lu X; Micewicz ED; Chodon T; Atefi M; Kroeger N; Chandramouli GV; Li G; Said JW; McBride WH; Kabbinavar FF; Ribas A; Pantuck AJ; Belldegrun AS; Riss J
    J Immunother; 2013 Feb; 36(2):102-11. PubMed ID: 23377663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-immunization with L-Myc enhances CD8
    Chai D; Zhang Z; Jiang N; Ding J; Qiu D; Shi SY; Wang G; Fang L; Li H; Tian H; Yang J; Zhang Q; Zheng J
    Cancer Sci; 2021 Sep; 112(9):3469-3483. PubMed ID: 34157192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma.
    Faiena I; Comin-Anduix B; Berent-Maoz B; Bot A; Zomorodian N; Sachdeva A; Said J; Cheung-Lau G; Pang J; Macabali M; Chodon T; Wang X; Cabrera P; Kaplan-Lefko P; Chamie K; Belldegrun AS; Pantuck AJ; Drakaki A
    J Immunother; 2020; 43(9):273-282. PubMed ID: 32925563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of renal cell carcinoma vaccines targeting carbonic anhydrase IX using heat shock protein 110.
    Kim HL; Sun X; Subjeck JR; Wang XY
    Cancer Immunol Immunother; 2007 Jul; 56(7):1097-105. PubMed ID: 17146628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors.
    Tatari N; Zhang X; Chafe SC; McKenna D; Lawson KA; Subapanditha M; Shaikh MV; Seyfrid M; Savage N; Venugopal C; Moffat J; Singh SK
    Front Immunol; 2022; 13():905768. PubMed ID: 35874663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of MN/CA IX antigen in carcinogenesis and metastasis of renal cell carcinoma].
    Nakagawa Y; Uemura H; Shimizu K; Cho M; Yoshikawa M; Hirao Y; Yoshikawa K
    Hinyokika Kiyo; 2001 Nov; 47(11):809-14. PubMed ID: 11771176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib improves adoptive carbonic anhydrase IX‑specific chimeric antigen receptor‑modified NK92 cell therapy in mouse models of human renal cell carcinoma.
    Zhang Q; Xu J; Ding J; Liu H; Li H; Li H; Lu M; Miao Y; Wang Z; Fu Q; Zheng J
    Oncol Rep; 2018 Dec; 40(6):3714-3724. PubMed ID: 30272343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma.
    Uemura H; Fujimoto K; Tanaka M; Yoshikawa M; Hirao Y; Uejima S; Yoshikawa K; Itoh K
    Clin Cancer Res; 2006 Mar; 12(6):1768-75. PubMed ID: 16551861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CA9 gene expression in conventional renal cell carcinoma: a potential marker for prediction of early metastasis after nephrectomy.
    Li G; Feng G; Gentil-Perret A; Genin C; Tostain J
    Clin Exp Metastasis; 2007; 24(3):149-55. PubMed ID: 17390110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells.
    Kurokawa T; Oelke M; Mackensen A
    Int J Cancer; 2001 Mar; 91(6):749-56. PubMed ID: 11275975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic effector cells with antitumor activity can be amplified ex vivo from biopsies or blood of patients with renal cell carcinoma for cell therapy use.
    Bouet-Toussaint F; Patard JJ; Gervais A; Genetet N; de la Pintière CT; Rioux-Leclercq N; Toutirais O; Thirouard AS; Ramée MP; Catros-Quemener V
    Cancer Immunol Immunother; 2003 Nov; 52(11):699-707. PubMed ID: 12879292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.